BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 541483)

  • 21. [Induction for termination of pregnancy in the second trimester and for delivery of babies dead in utero using intramuscular injections of 15-methyl-PGF2 alpha (author's transl)].
    Kunz B; De Grandi P
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(4):375-84. PubMed ID: 7299101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative studies on the termination of intact and disturbed pregnancies by intramuscular application of 15(s)-15-methyl-prostaglandin F2alpha (author's transl)].
    Schridde H; Hickl EJ
    Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):845-8. PubMed ID: 700344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic abortion during the second trimester of pregnancy, using intracervical injection of PgF2 alpha (author's transl)].
    Maria B; Blot P; Sureau C
    Nouv Presse Med; 1981 May; 10(22):1825-7. PubMed ID: 7232171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of abortion by intra-amniotic administration of prostaglandin F2 alpha in patients with intrauterine fetal death and missed abortion.
    Antsaklis A; Diakomanolis E; Karayannopoulos C; Aravantinos D; Kaskarelis D
    Int Surg; 1979; 64(5):41-3. PubMed ID: 299443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Induction of internal abortion, of hydatidiform mole in the 2d and 3d trimesters of pregnancy, with a dead fetus, using transcervical intra-amniotic injection of PGF2 alpha].
    Rizzuto E; D'Urso G
    Minerva Ginecol; 1977 Oct; 29(10):775-800. PubMed ID: 593617
    [No Abstract]   [Full Text] [Related]  

  • 26. [Local application of prostaglandin F2 alpha to primigravid interruption patients in first trimester].
    Heinz M; Günther H; Pundrich C
    Zentralbl Gynakol; 1982; 104(13):784-90. PubMed ID: 6958145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized double blind study of a new ready-for use prostaglandin gel (Org 2436) for cervical ripening prior to first trimester pregnancy termination.
    Osmers R; Rath W; Conrad A; Kuhn W
    Zentralbl Gynakol; 1990; 112(9):545-54. PubMed ID: 2378185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extra-amniotic prostaglandin E2 for midtrimester termination of pregnancy in live fetuses vs. fetal demise.
    Debby A; Sagiv R; Girtler O; Sadan O; Glezerman M; Golan A
    Arch Gynecol Obstet; 2003 Oct; 268(4):301-3. PubMed ID: 14504874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic interruption of pregnancy in the second trimester after preparation of the cervix with prostaglandins F2 alpha].
    Maria B; Stampf F; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(5):545-52. PubMed ID: 6581224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [First experience with extra-amniotic intrauterine administration of prostaglandin F2 alpha].
    Rotta L
    Cesk Gynekol; 1983 Nov; 48(9):643-7. PubMed ID: 6580965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experiences with a new priming score for estimation of efficiency of PGF2 alpha-gel for cervical maturation in first trimester induced abortion.
    Göretzlehner G; Köhler G; Schuchart A; Nikschick S
    Acta Chir Hung; 1986; 27(3):131-6. PubMed ID: 3469839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two different methods of prostaglandin administration for cervix priming before interruption of the first trimester pregnancy.
    Veszprémi B; Halvax L; Csaba IF
    Acta Chir Hung; 1987; 28(1):27-30. PubMed ID: 3473856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Continuous extra-amniotic intracavitary application of prostaglandin F2 alpha for medicamentous induction of labour in high-risk cases of pregnancy interruption].
    Ehrig E; Schott G
    Zentralbl Gynakol; 1982; 104(13):769-76. PubMed ID: 6958143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Labor induction by intra-amniotic administration of prostaglandin F 2 alpha].
    Halle H; Hengst P; Lau HU
    Zentralbl Gynakol; 1975; 97(19):1160-5. PubMed ID: 1189790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol. A comparative study.
    Ghorab MN; El Helw BA
    Acta Obstet Gynecol Scand; 1998 Apr; 77(4):429-32. PubMed ID: 9598952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extra-amniotic prostaglandin E2 and intravenous oxytocin in termination of mid-trimester pregnancy and the management of missed abortion and hydatiform mole.
    Arshat H
    Med J Malaysia; 1977 Mar; 31(3):220-5. PubMed ID: 904515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Induction of labor by prostaglandin F 2 alpha in the treatment of hydatidiform mole].
    Klausch B; Kruse HJ; Göretzlehner G; Büttner HH
    Zentralbl Gynakol; 1976; 98(22):1352-5. PubMed ID: 1007694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blood levels of primary prostaglandins along with use of Minprostin F2 alpha in the first trimester].
    Seifert B; Hassler MP
    Zentralbl Gynakol; 1982; 104(13):777-83. PubMed ID: 6958144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative administration of prostaglandin to avoid dilatation-induced damage in first-trimester pregnancy terminations.
    Heinzl S; Andor J
    Gynecol Obstet Invest; 1981; 12(1):29-36. PubMed ID: 7250779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Priming and medical abortion induction by PGF2 alpha].
    Kröner M; Graumüller G
    Zentralbl Gynakol; 1986; 108(16):995-1002. PubMed ID: 3465127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.